NVS Stock Price, Chart, Stats & News

Novartis AG
Save
NVS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.73% |
Operating margin | 31.25% |
Pretax margin | 29.12% |
Net margin | 24.90% |
Effective tax rate | 14.59% |
ROA | 12.10% |
ROE | 32.75% |
D/E | 0.80x |
Interest coverage ratio | 15.28x |
NVS valuation
P/E | 22.01x |
P/S | 5.10x |
P/B | 6.14x |
P/CF | 14.82x |
P/FCF | 18.31x |
P/OCF | 14.82x |
PEG | -9.32x |
EV multiple | 11.43x |
About
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Similar securities
Based on sector and market capitalization
Report issue











